Overcoming COVID-19 vaccine hesitancy: can Australia reach the last 20 percent?

Click to increase image sizeClick to decrease image size

Funding

This paper was not funded.

Author contribution statement

All authors were involved in the conceptualisation, design and drafting of the review perspective and revised it for intellectual content. JK an JT are equal joint first authors.

Declaration of interest

The institution of all three authors, Murdoch Children’s Research Institute, receives funding from the Commonwealth and Victorian Department of Health for COVID-19 vaccine social research. Jane Tuckerman is an investigator on a project grant sponsored by Industry. Her institution has received funding from Industry (GlaxoSmithKline) for investigator-led research. She does not receive any personal payments from Industry. Margie Danchin receives funding from the National Health and Medical Research Council (GNT 1164200) and the Victorian Department of Health. She is a member of the Australian Technical Advisory Group on Immunisation and is a Specialist Advisor to the Vaccine Safety Investigation Group of the Therapeutic Goods Administration. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.